Axon Capital LP Mckesson Corp Transaction History

Axon Capital LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2019 May 15, 2019	SELL	$111.86 - $136.3 $2.71 Million - $3.3 Million	-24,212 Closed	0 $0
Q4 2018 Feb 14, 2019	SELL	$108.23 - $136.84 $3.16 Million - $4 Million	-29,200 Reduced 54.67%	24,212 $2.68 Million
Q3 2018 Nov 14, 2018	SELL	$123.14 - $138.52 $923,550 - $1.04 Million	-7,500 Reduced 12.31%	53,412 $7.09 Million
Q2 2018 Aug 14, 2018	SELL	$133.4 - $158.13 $2.05 Million - $2.44 Million	-15,400 Reduced 20.18%	60,912 $8.13 Million
Q1 2018 May 15, 2018	BUY	$138.75 - $176.72 $4.08 Million - $5.2 Million	29,400 Added 62.67%	76,312 $10.8 Million
Q4 2017 Feb 14, 2018	SELL	$135.02 - $162.6 $5.24 Million - $6.31 Million	-38,800 Reduced 45.27%	46,912 $7.32 Million
Q3 2017 Nov 14, 2017	BUY	$146.0 - $161.87 $1.85 Million - $2.06 Million	12,700 Added 17.39%	85,712 $13.2 Million
Q2 2017 Aug 14, 2017	BUY	N/A	73,012	73,012 $12.1 Million

1,691

108M

1.66M

968K

Ticker MCK
Exchange NYSE
Sector Healthcare
Industry Medical Distribution
Shares Outstandng 143,730,000
Market Cap $82.9B
Description
McKesson Corporation provides healthcare services in the United States and internationally. It operates through four segments: U.S. Pharmaceutical, International, Medical-Surgical Solutions, and Prescription Technology Solutions (RxTS). The U.S. Pharmaceutical segment distributes branded, generic, specialty, biosimilar, and over-the-counter phar...

Get notified when there are updates to the investment portfolio of Axon Capital LP, based on Form 13F filings with the SEC.

Stay updated on Axon Capital LP with notifications on news.